Initial frontal fibrosing alopecia treatment was largely similar in Black and White patients, though tetracycline use was ...

An analysis of AccessHope case reviews found that experts recommended changes in more than 80% of cases. About half were ...

About half of patients with chronic hepatitis B or C also had MASLD, which tracked with worse fatigue and quality of life.

Patients with generalized myasthenia gravis who responded best to efgartigimod were not the ones with the biggest drop in ...

HHS enforcement discretion lets state pharmacies compound BPC-157 and other peptides amid rulemaking and legal challenges.

HHS does not intend to take enforcement action against pharmacies compounding BPC-157 and 5 other unapproved peptides if they ...

Sujith Ramachandran, PhD, associate director of Trinity Life Sciences, grouped access barriers into 3 buckets: upfront ...

A clinical-note analysis of more than 1000 patients found rising off-label BPC-157 use for pain and healing, with outcomes ...

At an AJMC® Stakeholder Interchange in Los Angeles, leukemia specialists described a region where hospital formularies push ...

Frailty, but not HIV serostatus, is tied to more severe lower urinary tract symptoms in adults with and at risk for HIV, a ...

The number of approvals is really only 1 piece of the pie,” said Nicole A. Caffiero, PharmD, MBA, BCACP, senior clinical ...

At AMCP Nexus 2026, Susan M. Wescott, RPh, MBA, discussed how health plans evaluate rare disease therapies amid limited data ...